ATP-citrate synthase Antibodies

Santa Cruz Biotechnology provides a broad selection of ATP-citrate synthase monoclonal antibodies for research in cellular metabolism. ATP-citrate synthase monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATP-citrate synthase is a key enzyme in the citric acid cycle, catalyzing the conversion of acetyl-CoA and oxaloacetate to citrate, which is essential for energy production and biosynthetic processes. The enzyme plays a significant role in regulating metabolic pathways, influencing lipid synthesis and cellular energy homeostasis. Understanding ATP-citrate synthase function and regulation provides valuable insights into metabolic disorders. Research focusing on ATP-citrate synthase contributes to identifying new therapeutic approaches for metabolic conditions. ATP-citrate synthase investigation helps reveal the complex relationship between cellular metabolism and disease progression. ATP-citrate synthase monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of metabolic regulation and its impact on human health.